BioSpace News Archive

During April, IBS Awareness Month, biotech company Glycom is offering a free trial offer of Holigos® IBS Restore for people suffering from abdominal pain, bloating, constipation or diarrhea caused by irritable bowel syndrome (IBS). Patients with IBS will need to reach out to their healthcare professionals to obtain their free product sample.

Production, New Orders, and Employment Contracting; Supplier Deliveries Slowing at Faster Rate; Backlog Contracting; Raw Materials Inventories Contracting; Customers’ Inventories Too Low; Prices Decreasing; Exports and Imports Contracting

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced the expansion of their renowned Certified Duchenne Care Center Program (CDCCP) with the program’s second Adult Certified Duchenne Care Center and first dually-certified center, the clinic at Kennedy Krieger Institute.

Individuals with the rare disease sarcoidosis live with concerns about their vulnerable health. The novel coronavirus disease, COVID-19, presents new risk and uncertainty for those with compromised immune systems.

Immunovia AB (publ) (“Immunovia”) today provides an update on the actions that the company is taking to support patients, employees, and public health initiatives in response to the coronavirus (COVID-19) pandemic. Despite these extraordinary times, Immunovia remains focused on the Q3 2020 sales start for the first test for early dia

worried about the novel coronavirus COVID-19 – are eschewing in-office visits and turning to behemoth telemedicine companies that connect them remotely with a doctor they’ve never met.

Company takes specific actions around mask and PPE production, product innovation and education

Kannalife, Inc., a biopharmaceutical medchem company specializing in the research and development of potent novel monotherapeutics, announced that the Company has been issued a Notice of Allowance from the United States Patent and Trademark Office for its trademark application for the mark, “Atopidine”.

KIYATEC, Inc., a clinical-stage leader in ex vivo 3D cell culture testing that supports cancer drug development and drug therapy decision-making, announced today that it is making high-throughput RNA extraction services available to clinical laboratories nationwide that are conducting COVID-19 testing.

Surge for personal protective equipment (PPE) for facilities with confirmed COVID-19 patients varies from 3X to 17X, depending upon item.